Cargando…

A Case of Type 2 Hypersensitivity to Rasburicase Diagnosed with a Natural Killer Cell Activation Assay

Drug hypersensitivity reactions can lead to different clinical pictures depending on the underlying immunological mechanism. Diagnosis tests are already available to assess the most frequent drugs hypersensitivity reactions, which are mediated by specific IgE or T cells. However, it remains challeng...

Descripción completa

Detalles Bibliográficos
Autores principales: Viel, Sébastien, Pescarmona, Rémi, Belot, Alexandre, Nosbaum, Audrey, Lombard, Christine, Walzer, Thierry, Bérard, Frédéric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796899/
https://www.ncbi.nlm.nih.gov/pubmed/29434608
http://dx.doi.org/10.3389/fimmu.2018.00110
_version_ 1783297567765823488
author Viel, Sébastien
Pescarmona, Rémi
Belot, Alexandre
Nosbaum, Audrey
Lombard, Christine
Walzer, Thierry
Bérard, Frédéric
author_facet Viel, Sébastien
Pescarmona, Rémi
Belot, Alexandre
Nosbaum, Audrey
Lombard, Christine
Walzer, Thierry
Bérard, Frédéric
author_sort Viel, Sébastien
collection PubMed
description Drug hypersensitivity reactions can lead to different clinical pictures depending on the underlying immunological mechanism. Diagnosis tests are already available to assess the most frequent drugs hypersensitivity reactions, which are mediated by specific IgE or T cells. However, it remains challenging to diagnose type 2 hypersensitivity reactions (T2HR), which can lead to severe cytopenia and liver failure. Here, we describe a case of T2HR to rasburicase, an uricolytic agent used to prevent tumor lysis syndrome. In this patient, sensitization was associated with the production of specific IgG able to bind to leukocytes. We found that patient NK cells were specifically activated in the presence of rasburicase and autologous serum, which led to exocytosis of lytic granules. This antibody-dependent cell cytotoxicity mechanism may lead to cytopenia observed in the patient. Moreover, this NK cell activation assay could be used to improve the diagnosis of a T2HR to rasburicase and, by extent, to other drugs. These data also suggest that NK cells could play an important role in the pathophysiological mechanism of T2HR.
format Online
Article
Text
id pubmed-5796899
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-57968992018-02-12 A Case of Type 2 Hypersensitivity to Rasburicase Diagnosed with a Natural Killer Cell Activation Assay Viel, Sébastien Pescarmona, Rémi Belot, Alexandre Nosbaum, Audrey Lombard, Christine Walzer, Thierry Bérard, Frédéric Front Immunol Immunology Drug hypersensitivity reactions can lead to different clinical pictures depending on the underlying immunological mechanism. Diagnosis tests are already available to assess the most frequent drugs hypersensitivity reactions, which are mediated by specific IgE or T cells. However, it remains challenging to diagnose type 2 hypersensitivity reactions (T2HR), which can lead to severe cytopenia and liver failure. Here, we describe a case of T2HR to rasburicase, an uricolytic agent used to prevent tumor lysis syndrome. In this patient, sensitization was associated with the production of specific IgG able to bind to leukocytes. We found that patient NK cells were specifically activated in the presence of rasburicase and autologous serum, which led to exocytosis of lytic granules. This antibody-dependent cell cytotoxicity mechanism may lead to cytopenia observed in the patient. Moreover, this NK cell activation assay could be used to improve the diagnosis of a T2HR to rasburicase and, by extent, to other drugs. These data also suggest that NK cells could play an important role in the pathophysiological mechanism of T2HR. Frontiers Media S.A. 2018-01-29 /pmc/articles/PMC5796899/ /pubmed/29434608 http://dx.doi.org/10.3389/fimmu.2018.00110 Text en Copyright © 2018 Viel, Pescarmona, Belot, Nosbaum, Lombard, Walzer and Bérard. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Viel, Sébastien
Pescarmona, Rémi
Belot, Alexandre
Nosbaum, Audrey
Lombard, Christine
Walzer, Thierry
Bérard, Frédéric
A Case of Type 2 Hypersensitivity to Rasburicase Diagnosed with a Natural Killer Cell Activation Assay
title A Case of Type 2 Hypersensitivity to Rasburicase Diagnosed with a Natural Killer Cell Activation Assay
title_full A Case of Type 2 Hypersensitivity to Rasburicase Diagnosed with a Natural Killer Cell Activation Assay
title_fullStr A Case of Type 2 Hypersensitivity to Rasburicase Diagnosed with a Natural Killer Cell Activation Assay
title_full_unstemmed A Case of Type 2 Hypersensitivity to Rasburicase Diagnosed with a Natural Killer Cell Activation Assay
title_short A Case of Type 2 Hypersensitivity to Rasburicase Diagnosed with a Natural Killer Cell Activation Assay
title_sort case of type 2 hypersensitivity to rasburicase diagnosed with a natural killer cell activation assay
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796899/
https://www.ncbi.nlm.nih.gov/pubmed/29434608
http://dx.doi.org/10.3389/fimmu.2018.00110
work_keys_str_mv AT vielsebastien acaseoftype2hypersensitivitytorasburicasediagnosedwithanaturalkillercellactivationassay
AT pescarmonaremi acaseoftype2hypersensitivitytorasburicasediagnosedwithanaturalkillercellactivationassay
AT belotalexandre acaseoftype2hypersensitivitytorasburicasediagnosedwithanaturalkillercellactivationassay
AT nosbaumaudrey acaseoftype2hypersensitivitytorasburicasediagnosedwithanaturalkillercellactivationassay
AT lombardchristine acaseoftype2hypersensitivitytorasburicasediagnosedwithanaturalkillercellactivationassay
AT walzerthierry acaseoftype2hypersensitivitytorasburicasediagnosedwithanaturalkillercellactivationassay
AT berardfrederic acaseoftype2hypersensitivitytorasburicasediagnosedwithanaturalkillercellactivationassay
AT vielsebastien caseoftype2hypersensitivitytorasburicasediagnosedwithanaturalkillercellactivationassay
AT pescarmonaremi caseoftype2hypersensitivitytorasburicasediagnosedwithanaturalkillercellactivationassay
AT belotalexandre caseoftype2hypersensitivitytorasburicasediagnosedwithanaturalkillercellactivationassay
AT nosbaumaudrey caseoftype2hypersensitivitytorasburicasediagnosedwithanaturalkillercellactivationassay
AT lombardchristine caseoftype2hypersensitivitytorasburicasediagnosedwithanaturalkillercellactivationassay
AT walzerthierry caseoftype2hypersensitivitytorasburicasediagnosedwithanaturalkillercellactivationassay
AT berardfrederic caseoftype2hypersensitivitytorasburicasediagnosedwithanaturalkillercellactivationassay